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Abstract: Supplement users (SU) make healthy lifestyle choices; on the other hand, SU 
report more medical conditions. We hypothesised that cod liver oil (CLO) consumers are 
similar to non-supplement users, since CLO use might originate from historical motives, i.e., 
rickets prevention, and not health consciousness. CLO consumers were studied in order to 
identify possible confounders, such as confounding by indication. The European Prospective 
Investigation into Cancer (EPIC) investigates causes of chronic disease. The participants 
were 25,639 men and women, aged 40–79 years, recruited from general practices in Norfolk, 
East-Anglia (UK). Participants completed questionnaires and a health examination between 
1993 and 1998. Supplement use was measured using 7-day diet diaries. CLO was the most 
common supplement used, more prevalent among women and associated with not smoking, 
higher physical activity level and more favourable eating habits. SU had a higher occurrence 
of benign growths and bone-related diseases, but CLO was negatively associated with 
cardiovascular-related conditions. Although the results of SU characteristics in EPIC-Norfolk 
are comparable with studies worldwide, the CLO group is different from SU in general. 
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Confounding by indication takes place and will need to be taken into account when analysing 
prospective associations of CLO use with fracture risk and cardiovascular diseases. 
Keywords: dietary supplement; cod liver oil; socio-demographics; health; confounding; 
cardiovascular disease 
 
1. Introduction 
Since the 19th century, cod liver (CLO), for its source of vitamin D, has been used as one of  
the remedies to cure rickets [1]. It has been the most commonly used supplement in the UK for  
decades [2–6]. In EPIC-Norfolk, 32% of men and 45% of women used dietary supplements between 
1993 and 1998 [7] with nearly 25% of all participants consuming CLO [8]. Special interest in CLO 
supplement use is warranted for several reasons. Firstly, for its nutrients, CLO contains eicosapentaenoic 
acid and docosahexaenoic acid, which in observational studies have been negatively associated with 
several cancer sites [9,10]; on the other hand, meta-analyses of trial and/or cohort data have shown no 
effect of these omega-3 fatty acids in supplement form on cardiovascular disease [11,12]. CLO also 
provides vitamins A, D and E of which vitamin D prevents osteomalacia and has been associated with 
osteoporosis [13]; while chronic intake above 1500 µg/day of vitamin A might increase the risk of 
fractures [14]. Secondly, methodological reasons: there is no such person as “a supplement user” [5,15], 
supplement users (SU) are heterogeneous and ignoring these differences can lead to bias [16]. These 
differences are not only due to lifestyle [17], but also to what is referred to as “confounding by 
indication” [5,18,19]. Meaning that certain co-morbidities make the use of certain dietary supplements 
more likely, which, if not taken into account, could lead to the conclusion that there is an association 
between the exposure, i.e., dietary supplements, and outcome (e.g., fracture) when in fact the co-morbidity 
(e.g., osteoporosis) is merely an indication for, or increases, supplement use. 
Before public health messages can be formulated to encourage or discourage CLO use, also in the 
light of possible harmful effects when overdosed [20], a careful analysis of eating habits and other 
possible confounders in CLO consumers will have to precede this [16]. Supplement use in general in the 
United Kingdom [3–5,21], Europe [22], the United States [23] and Australia [24,25] has been associated 
with socio-demographic factors such as being a woman, being older, having a higher socio-economic 
status; behaviour-wise, SU exercise more, smoke less, eat more healthily and have a lower body mass 
index (BMI). Whether CLO consumers share the same characteristics as SU in general, and as a result 
would confound the association found between CLO consumption and health, requires further study. 
The high proportion of CLO consumers, as well as the detailed information collected in this aging cohort, 
puts EPIC-Norfolk in a position to study such associations. 
This paper describes the socio-demographics, eating habits, anthropometry and self-reported  
health of NSU and SU in EPIC-Norfolk, with a special focus on the most commonly consumed 
supplement: CLO. 
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2. Methods 
2.1. Study Design and Participant Selection 
This study was conducted according to the guidelines laid down in the Declaration of Helsinki and 
all procedures were approved by the Norfolk District Health Authority Ethics Committee. Written 
informed consent was obtained from all participants. The study started in 1993 with participants aged 
between 40 and 79 years. Participants lived in the Norfolk area of East Anglia and were recruited from 
general practitioners’ (GP) age-sex registers [26]. Of the 77,630 invited participants, 30,447 gave their 
informed consent and received a Health and Lifestyle Questionnaire. Of this group, 25,639 attended a 
health examination at their GP-clinic and were given a 7-day Diet Diary (7dDD). 
2.2. Data Collection 
The Health and lifestyle Questionnaire was sent to the participants in advance of their GP clinic 
appointment. Participants were asked about the following: smoking habits (never, former or current 
smoker); final level of education obtained (no qualifications, O-level, A-level, Degree or equivalent); 
current profession, from which socio-economic class was derived (unskilled, semi-skilled, skilled 
manual, skilled non-manual, managerial or professional); marital status (married, single, widowed, 
divorced or separated); a validated physical activity score combining occupational and recreational 
physical activity (active, moderately active, moderately inactive, inactive) [27]; and self-reported 
illnesses, such as cardiovascular diseases, diabetes, cancer and osteoporosis, measured by the question: 
“Has the doctor ever told you that you have any of the following”. The participant’s postcode was linked 
to the Townsend residential area deprivation score. This score identifies material deprivation by using 
four components: unemployment, non-car ownership, non-house ownership and overcrowding, i.e., the 
number of people who live per room in a house [28]. 
Participants were taken through the research protocol by a trained nurse [26]. During the health 
examination, weight (kg) and height (cm) were measured from which Body Mass Index (BMI) was 
calculated (kg/m2). 
A 7dDD was handed out at the health examination [29,30]. This diary was a 45-page, A5 booklet, 
with detailed instructions regarding how food and drink should be recorded, as well as seventeen series 
of colour photos, depicting portions of food items on plates in increasing quantities. The nurse completed 
a 24-h diet recall as a means of instruction (n = 25,507; 99%). The remainder of the 7dDD was completed 
at the participant’s home, 23,638 (92%) of the participants completed more than one day. 
The 7dDD ended with general questions, referred to as the “Back Of Diary (BOD)”, and was 
completed by 23,309 (91%) participants [8]. The BOD included the question relating to supplement use 
(“Please name any vitamins, minerals or other food supplements taken on each day of last week”). If 
this question was left open, crossed out or answered with “no/none”, then participants were categorised 
as NSU; however, if participants had recorded any supplements taken, they were categorised as SU. 
Kappa-statistics with instruments recalling supplement use over the past year in EPIC-Norfolk ranged 
from 0.72–0.78 [7]. Supplements were coded according to the Vitamin and Minerals Supplement 
(ViMiS) system described in detail elsewhere [8]. Summarised, supplements were grouped into  
45 distinct groups of which CLO was one. This group included CLO or any other type of fish oil, and 
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CLO supplements combined with multivitamins or with, for example, evening primrose oil in the same 
capsule. For the purpose of this analysis, participants who reported medication containing vitamins 
and/or minerals without further supplement use were classified as NSU. 
The 7dDD were entered by trained data-entry clerks using a program called DINER, Data Into 
Nutrients for Epidemiological Research [30] and checked and calculated by nutritionists using 
DINERMO [31]. Alcohol intake in grams was divided by 8 to obtain the number of units in alcoholic 
beverages. Food group data were calculated by summing the weight of each food item consumed, 
belonging to either fruit, vegetables, red, white or processed meat or white and fatty fish, as well as the 
percentage contribution to these food groups from composite food items (e.g., Beef stew including 
vegetables) [31]. These food groups were chosen because of established associations with cancer and 
cardiovascular risk factors [32]. 
2.3. Statistical Analysis 
The characteristics of participants were compared using two different groupings. First, NSU vs. SU, 
followed by two SU subgroups in order to elucidate possible confounding factors for CLO users: 
SU+CLO, participants who used CLO or supplements where cod liver oil/fish oil was an ingredient, also 
when used in combination with non-CLO supplements (i.e., multiple supplement users of which at least 
one contained CLO); SU-CLO, participants who consumed one or more supplements that did not  
contain CLO. 
Both comparisons were firstly carried out without adjustment, stratified by sex, using the Chi-squared 
statistic, followed by multivariable binary (SU vs. NSU) and multinomial (SU+CLO vs. NSU  
and SU-CLO vs. NSU) logistic regression to compare these groups adjusted for all presented  
socio-demographic variables. 
Differences in food consumption between NSU and SU groups were tested using the Mann-Whitney 
U and Kruskal-Wallis statistic. Associations between self-reported illnesses and supplement use were 
adjusted for age using multinomial logistic regression, with supplement use as the dependent variable 
(NSU/SU+CLO/SU-CLO). Analyses were performed using SPSS v19 (IBM Corp., Armonk, NY, USA). 
p-values below 0.05 were considered significant. 
3. Results 
3.1. Supplement Consumption 
Out of 23,039 participants who answered the BOD, 3253 (31.7%) of men (n = 10,247) and  
5736 (44.8%) of women (n = 12,792) used a supplement (χ2 (1) = 410.01, p < 0.001). A total of 5262 
and 10,732 supplements were consumed by men and women respectively. For both men and women, 
CLO was the most commonly consumed supplement (43% and 32% respectively), followed by garlic 
(12%) and multivitamins (11%) for men and multivitamins (11%) and evening primrose oil (10%) for 
women. For CLO supplements, 94% of men and 96% of women used these on a daily basis compared 
to 89% and 90% respectively for non-CLO supplements. CLO supplements were consumed by 22% of 
men and 26% of women. Only 10% of men consumed supplements that did not contain CLO, compared 
to 19% of women. 
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3.2. Socio-Demographic Characteristics of Supplement Users 
Supplement use in general was associated with sex-dependent characteristics (see columns NSU and 
SU in Table 1 for men and Table 2 for women). Male SU were older than NSU, whereas female SU 
completed higher levels of education than female NSU. Marital status was not, and Townsend score only 
weakly, associated with supplement use. All other characteristics had, in general, stronger associations 
among women compared to men. In summary, supplement use indicated a healthier lifestyle and higher 
socio-economic class. 
The characteristics of the participants who consumed a supplement that contained CLO (SU+CLO) 
vs. NSU and participants who consumed other types of supplements (SU-CLO) vs. NSU (see Table 1 
and Table 2), resulted in stronger associations with socio-demographic characteristics with supplement 
use, especially among women. Notably, younger age in women was strongly associated with the  
SU-CLO category, similarly for higher education level; however, such associations among SU+CLO 
were not present. In men, not being married as well as a higher education level, though not associated 
with supplement use in general, was associated with SU-CLO. 
Results of the fully adjusted analysis (NSU vs. SU) are to be found in Table 1 and Table 2 (see column 
SU vs. NSU). 3.6% of the participants were lost due to missing values for one or more variables (n = 
22,205). For supplement use in general, results remained the same as in the unadjusted analysis, except 
for the area deprivation score in both sexes. Smoking had the strongest association with supplement use, 
decreasing the odds of supplement use with 41% in men and 29% in women; followed by physical 
inactivity in men and winter season and lower social class in women. The analysis was repeated with 
sex in the model (data not shown) and showed a significant independent effect of sex on supplement use 
in general (OR = 0.54; 95% CI: 0.51–0.58). 
Multinomial logistic regression compared NSU with the two SU subgroups (SU+CLO and  
SU-CLO, see last two columns in Table 1 and Table 2). Results were similar compared to the unadjusted 
analysis, with exception of education level among men and area deprivation score in both sexes, which 
lost their significance. Strongest associations were again seen for current smoking; other variables, 
particularly social class and education, were more strongly associated with the SU-CLO group and not 
with the SU+CLO group when compared to supplement use in general. 
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Table 1. Characteristics of European Prospective Investigation into Cancer (EPIC)-Norfolk participants (men only) according to supplement 
status (Non-supplement User (NSU)/Supplement User (SU)) and supplement subgroup (NSU/SU+cod liver oil (CLO)/SU-CLO). Analyses are 
shown unadjusted (Chi-squared test). Logistic regression (NSU/SU) and multinomial logistic regression (NSU/SU+CLO/SU-CLO) were adjusted 
for all variables in this table (n = 9943). Boldly printed OR were statistically significant findings. 
MEN 
NSU  
N 
% 
SU  
N 
% 
SU+CLO  
N 
% 
SU-CLO  
N 
% 
SU vs. NSU  
OR 
95% CI 
SU+CLO vs. NSU  
OR 
95% CI 
SU-CLO vs. NSU  
OR 
95% CI 
Age 6994  3253  2215  1038        
<=50 years 1696 24.2 528 16.2 285 12.9 243 23.4 1.15 1.12–1.18 1.21 1.17–1.24 1.05 1.01–1.09 
>50–60 years 2199 31.4 950 29.2 649 29.3 301 29.0 OR represents the % change in odds of being 
>60–70 years 2120 30.3 1218 37.4 876 39.5 342 32.9 a SU for every 5 year increment in age 
>70 years 979 14.0 557 17.1 405 18.3 152 14.6  
 χ2 (3) = 118.51, p < 0.001 χ2 (6) = 170.43, p < 0.001        
Marital status 6967  3227  2198  1029        
Married 6110 87.7 2839 88.0 1956 89.0 883 85.8 Ref  Ref  Ref  
Not married a 857 12.3 388 12.0 242 11.0 146 14.2 1.01 0.88–1.15 0.88 0.75–1.03 1.30 1.07–1.58 
 χ2 (1) = 0.16, n.s. χ2 (2) = 6.76, p < 0.05        
Social class 6881  3197  2174  1023        
Non-Manual b 3935 57.2 1961 61.3 1265 58.2 696 68.0 Ref  Ref  Ref  
Manual c 2946 42.8 1236 38.7 909 41.8 327 32.0 0.87 0.79–0.95 1.00 0.90–1.11 0.63 0.55–0.74 
 χ2 (1) = 15.50, p < 0.001 χ2 (2) = 43.29, p < 0.001        
Education level 6991  3249  2211  1038        
Any qualification d 4829 69.1 2276 70.1 1508 68.2 768 74.0 Ref  Ref  Ref  
No qualifications 2162 30.9 973 29.9 703 31.8 270 26.0 0.93 0.84–1.03 0.95 0.84–1.06 0.89 0.76–1.05 
 χ2 (1) = 1.00, n.s. χ2 (2) = 12.12, p < 0.01        
Townsend index e 6968  3245  2211  1034        
Score < 0 5859 84.1 2786 85.9 1910 86.4 876 84.7 Ref  Ref  Ref  
Score > 0 1109 15.9 459 14.1 301 13.6 158 15.3 0.93 0.82–1.05 0.88 0.76–1.02 1.04 0.86–1.26 
 χ2 (1) = 5.34, p < 0.05 χ2 (2) = 6.85, p < 0.05        
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Table 1. Cont. 
MEN 
NSU  
N 
% 
SU  
N 
% 
SU+CLO  
N 
% 
SU-CLO  
N 
% 
SU vs. NSU  
OR 
95% CI 
SU+CLO vs. NSU  
OR 
95% CI 
SU-CLO vs. NSU  
OR 
95% CI 
Smoking 6951  3226  2197  1029        
Never 2295 33.0 1111 34.4 730 33.2 381 37.0 Ref  Ref  Ref  
Former 3756 54.0 1872 58.0 1309 59.6 563 54.7 0.95 0.87–1.05 0.97 0.87–1.08 0.91 0.79–1.05 
Current 900 12.9 243 7.5 158 7.2 85 8.3 0.59 0.50–0.69 0.58 0.48–0.70 0.61 0.47–0.79 
 χ2 (2) = 65.22, p < 0.001 χ2 (4) = 71.95, p < 0.001        
Physical activity f 6991  3249  2211  1038        
(Moderately) 
active 
3060 43.8 1475 45.4 1000 45.2 475 45.8 Ref  Ref  Ref  
(Moderately) 
inactive 
3931 56.2 1774 54.6 1211 54.8 563 54.2 0.82 0.75–0.90 0.82 0.74–0.91 0.81 0.71–0.93 
 χ2 (1) = 2.38, n.s. χ2 (2) = 2.46, n.s.        
Start 7dDD g 6994  3252  2215  1037        
Spring/Summer 3507 50.1 1541 47.4 1066 48.1 475 45.8 Ref  Ref  Ref  
Autumn/Winter 3487 49.9 1711 52.6 1149 51.9 562 54.2 1.12 1.03–1.22 1.09 0.98–1.20 1.20 1.05–1.37 
 χ2 (1) = 6.75, p < 0.01 χ2 (2) = 8,27, p < 0.05        
NSU, Non-supplement User; SU, Supplement User; CLO, cod liver oil; χ2, Chi-squared test; OR, odds ratio; CI, confidence interval; Ref, Reference category. a Not married included the categories (NSU/SU): single 
(n = 290/128), widowed (n = 213/106), separated (n = 69/19) and divorced (n = 286/135); b Non-manual included the categories (NSU/SU): professional (n = 544/222), managerial (n = 2531/1315), skilled  
non-manual (n = 860/424); c Manual included the categories (NSU/SU): skilled manual (n = 1787/760), semi-skilled (n = 934/397) and non-skilled (n = 225/79); d Any qualification included (NSU/SU): O-level  
(n = 587/291), A-level (n = 3177/1518), Degree or equivalent (n = 1065/467); e Townsend index score < 0 means district in which the participant lives is more affluent than the mean in England; score > 0 means a 
district in which the participant lives is more deprived than the mean in England; f Included the categories (NSU/SU): active (1467/705), moderately active (1593/770), moderately inactive (1685/837), inactive 
(2246/937); g Created from first date in the diary; Spring: March-May, Summer: June-August, Autumn: September-November, Winter: December-February. 
 
Nutrients 2014, 6 4327 
 
Table 2. Characteristics of EPIC-Norfolk participants (women only) according to supplement status (NSU/SU) and supplement subgroup 
(NSU/SU+CLO/SU-CLO). Analysis are shown unadjusted (Chi-squared test). Logistic regression (NSU/SU) and multinomial logistic 
regression (NSU/SU+CLO/SU-CLO) were adjusted for all variables in this table (n = 12,262). Boldly printed OR were statistically  
significant findings. 
WOMEN 
NSU  
N 
% 
SU  
N 
% 
SU+CLO  
N 
% 
SU-CLO  
N 
% 
SU vs. NSU  
OR 
95% CI 
SU+CLO vs. 
NSU  
OR 
95% CI 
SU-CLO vs. NSU  
OR 
95% CI 
Age 7056  5736  3389  2347        
<=50 years 1833 26.0 1356 23.6 611 18.0 745 31.7 1.02 1.00–1.04 1.09 1.06–1.12 0.93 0.90–0.95 
>50–60 years 2185 31.0 1862 32.5 1107 32.7 755 32.2 OR represents the % change in odds of being 
>60–70 years 2100 29.8 1792 31.2 1170 34.5 622 26.5 a SU for every 5 year increment in age 
>70 years 938 13.3 726 12.7 501 14.8 225 9.6       
 χ2 (3) = 12.43 p < 0.01 χ2 (6) = 175.26 p < 0.001        
Marital status 7025  5691  3363  2328        
Married 5400 76.9 4315 75.8 2519 74.9 1796 77.1 Ref  Ref  Ref  
Not married a 1625 23.1 1376 24.2 844 25.1 532 22.9 1.06 0.98–1.16 1.06 0.96–1.17 1.06 0.94–1.20 
 χ2 (1) = 1.91 n.s. χ2 (2) = 5.75 n.s.        
Social class 6865  5612  3299  2313        
Non-Manual b 4063 59.2 3610 64.3 2049 62.1 1561 67.5 Ref  Ref  Ref  
Manual c 2802 40.8 2002 35.7 1250 37.9 752 32.5 0.84 0.78–0.91 0.90 0.82–0.99 0.76 0.69–0.85 
 χ2 (1) = 34.48 p < 0.001 χ2 (2) = 51.09 p < 0.001        
Education level 7052  5732  3386  2346        
Any qualification d 3942 55.9 3423 59.7 1869 55.2 1554 66.2 Ref  Ref  Ref  
No qualifications 3110 44.1 2309 40.3 1517 44.8 792 33.8 0.91 0.84–0.99 1.02 0.93–1.11 0.77 0.69–0.86 
 χ2 (1) = 18.88 p < 0.001 χ2 (2) = 88.08 p < 0.001        
Townsend index e 7030  5710  3375  2335        
Score <0 5845 83.1 4845 84.9 2851 84.5 1994 85.4 Ref  Ref  Ref  
Score >0 1185 16.9 865 15.1 524 15.5 341 14.6 0.91 0.82–1.01 0.91 0.81–1.02 0.91 0.80–1.05 
 χ2 (1) = 6.80 p < 0.01 χ2 (2) = 7.67 p < 0.05        
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Table 2. Cont. 
WOMEN 
NSU  
N 
% 
SU  
N 
% 
SU+CLO  
N 
% 
SU-CLO  
N 
% 
SU vs. NSU  
OR 
95% CI 
SU+CLO vs. 
NSU  
OR 
95% CI 
SU-CLO vs. 
NSU  
OR 
95% CI 
Smoking 6992  5680  3350  2330        
               
Never 3.949 56.5 3260 57.4 1939 57.9 1321 56.7 Ref  Ref  Ref  
Former 2179 31.2 1930 34.0 1162 34.7 768 33.0 1.08 1.00–1.17 1.07 0.98–1.17 1.09 0.98–1.21 
Current 864 12.4 490 8.6 249 7.4 24 10.3 0.71 0.63–0.80 0.61 0.53–0.72 0.85 0.72–0.99 
 χ2 (2) = 48.93 p < 0.001 χ2 (4) = 61.43 p < 0.001        
Physical activity f 7052  5732  3386  2346        
(Moderately) 
active 2561 
36.3 2259 39.4 1282 37.9 977 41.6 Ref  Ref  Ref  
(Moderately) 
inactive 4491 
63.7 3473 60.6 2104 62.1 1369 58.4 0.87 0.80–0.94 0.87 0.80–0.96 0.86 0.77–0.95 
 χ2 (1) = 12.89 p < 0.001 χ2 (2) = 21.34 p < 0.001        
Start 7dDD g 7056  5736  3389  2347        
Spring/Summer 3662 51.9 2765 48.2 1640 48.4 1125 47.9 Ref  Ref  Ref  
Autumn/Winter 3394 48.1 2971 51.8 1749 51.6 1222 52.1 1.16 1.08–1.25 1.15 1.06–1.26 1.17 1.07–1.29 
 χ2 (1) = 17.28 p < 0.001 χ2 (2) = 17.39 p < 0.001        
NSU, Non-supplement User; SU, Supplement User; CLO, cod liver oil; χ 2, Chi-squared test; CI, confidence interval; Ref, Reference category. a Not married includes the categories (NSU/SU): single (n = 281/230), 
widowed (n = 806/670), separated (n = 67/65) and divorced (n = 471/411); b Non-manual includes the categories (NSU/SU): professional (n = 421/372), managerial (n = 2343/2026), skilled non-manual  
(n = 1299/1212); c Manual includes the categories (NSU/SU): skilled manual (n = 1511/1115), semi-skilled (n = 971/702) and non-skilled (n = 320/185); d Any qualification included (NSU/SU): O-level (n = 830/640), 
A-level (n = 2363/2163), Degree or equivalent (n = 749/620); e Townsend index score < 0 means district in which the participant lives is more affluent than the mean in England; score > 0 means a district in which 
the participant lives is more deprived than the mean in England; f Included the categories (NSU/SU): active (1012/954), moderately active (1549/1305), moderately inactive (2186/1924), inactive (2305/1549);  
g Created from first date in the diary; Spring: March-May, Summer: June-August, Autumn: September-November, Winter: December-February. 
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3.3. Food Choices of Supplement Users 
SU in general consumed significantly more fruit, vegetables and fatty fish and less red and processed 
meat than NSU (Table 3). In both men and women, the lower intake of red and processed meats amongst 
SU in general appeared to be mainly driven by the SU-CLO group, which had a significantly lower 
intake compared to the SU+CLO group (p < 0.025). Although there were no associations between 
alcohol consumption and supplement use in men, we observed a higher proportion of alcohol consumers 
among women using supplements, particularly the SU-CLO group, as well as an increment in their 
median weekly intake (p < 0.025). 
3.4. Health and Supplement Use 
BMI was associated with both age and supplement use. The mean (95% CI), age-adjusted BMI for 
male NSU was 26.6 (26.5–26.7) kg/m2, for SU+CLO 26.3 (26.2–26.4) kg/m2 and for SU-CLO 26.1 
(25.9–26.2) kg/m2 (F = 15.6 [2;10217], p < 0.001). Among women, the association between supplement 
use and BMI was stronger; the mean BMI for female NSU was 26.4 (26.3–26.5) kg/m2, for SU+CLO 
25.9 (25.7–26.0) kg/m2 and for SU-CLO 25.6 (25.4–25.8) kg/m2 (F = 42.4 [2;12750], p < 0.001). 
In this cross-sectional study, the use of different types of dietary supplements was associated with 
self-reported illnesses (Table 4). For participants who reported having had benign growths, the odds of 
being a SU-CLO increased by 36% in men and 35% in women compared to NSU. Diseases affecting 
the heart and circulation were negatively associated with CLO supplement use and not associated with 
non-CLO supplement use. Men who reported having had a heart attack had a 42% lower odds of using 
CLO compared to men free of a prevalent heart attack; women who reported having been diagnosed 
with diabetes had a 50% reduced odds of being a SU+CLO. Participants who reported diseases that 
affect bone health were reporting more supplement use. Women who reported arthritis had a 60% 
increased odds of using CLO and 15% increased use of other types of supplements; similar results for 
CLO use were found for men. Women who reported osteoporosis had a 58% increased odds of using a 
non-CLO supplement. 
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Table 3. Comparison of food group intake distributions between Non-Supplement Users and Supplement Users (NSU/SU) and between SU 
subgroups (NSU/SU+CLO/SU-CLO) in the EPIC-Norfolk study. 
Food groups 
NSU 
Median 
IQR 
SU 
Median 
IQR 
SU+CLO 
Median 
IQR 
SU-CLO 
Median 
IQR 
p-value a 
NSU vs. SU 
p-value b 
NSU vs. SU+CLO  
vs. SU-CLO 
MEN (n) 6994  3252  2215  1037    
Fruit (g/day) 127 60–212 161 86–253 161 89–257 158 79–244 p < 0.001 p < 0.001 
Vegetables (g/day) 139 99–188 145 106–198 146 108–197 145 102–202 p < 0.001 p < 0.001 
Meat           
Red (g/day) 38 20–59 33 16–54 *34 16–55 31 14–52 p < 0.001 p < 0.001 
White (g/day) 22 7–40 22 7–40 22 8–40 21 6–40 n.s. n.s. 
Processed (g/day) 25 13–40 22 11–37 *23 12–38 21 9–35 p < 0.001 p < 0.001 
Fish           
White(g/day) 16 0–25 16 0–27 16 0–27 15 0–27 p < 0.01 p < 0.01 
Fatty (g/day) 1 0–19 8 0–24 7 0–24 8 0–24 p < 0.001 p < 0.001 
Alcoholic beverages (units/diary) 8.1 1.2–21.0 8.2 1.2–21.1 8.1 1.3–20.9 8.4 0.9–21.8 n.s. n.s. 
Alcohol consumers only (units/diary) c 13.0 5.3–25.5 13.0 5.4–25.5 12.8 5.1–25.1 13.9 6.0–26.8 n.s. n.s. 
WOMEN (n) 7056  5736  3389  2347    
Fruit (g/day) 151 83–238 180 107–267 *183 110–269 174 104–263 p < 0.001 p < 0.001 
Vegetables (g/day) 136 97–183 145 107–194 145 108–192 146 105–197 p < 0.001 p < 0.001 
Meat           
Red (g/day) 27 12–45 24 9–41 *25 10–42 23 7–40 p < 0.001 p < 0.001 
White (g/day) 18 5–34 19 6–35 19 5–36 19 6–35 p < 0.05 n.s. 
Processed (g/day) 16 7–27 14 6–25 *15 6–25 14 4–24 p < 0.001 p < 0.001 
Fish           
White (g/day) 12 0–21 12 0–22 *13 0–23 11 0–21 n.s. p < 0.001 
Fatty (g/day) 3 0–16 6 0–20 6 0–21 6 0–19 p < 0.001 p < 0.001 
Alcoholic beverages (units/diary) 2.1 0.0–9.2 3.3 0–10.3 *3.1 0.0–9.8 3.9 0.0–11.2 p < 0.001 p < 0.001 
Alcohol consumers only (units/diary) d 6.9 3.0–14.6 7.3 3.3–14.7 *7.0 3.2–14.1 7.7 3.5–15.2 n.s. p < 0.05 
NSU, Non-supplement User; SU, Supplement User; CLO, cod liver oil; IQR, Inter Quartile Range. a Differences between groups tested using Mann-Whitney U test; b Differences between groups tested using  
Kruskal-Wallis test and if significant, followed by Mann-Whitney U test to test for differences in SU subgroups. p-values < 0.025 were considered significant (Bonferroni correction applied: 0.05/2, marked with an * in 
the SU+CLO column); c Men: NSU n = 5411 (77%), SU+CLO n = 1748 (79%), SU-CLO n = 799 (77%); d Women: NSU n = 4352 (62%) , SU+CLO n = 2233 (66%), SU-CLO n = 1611 (69%); * p-value < 0.025 
(see also footnote b). 
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Table 4. Differences in self-reported health between non-supplement users (NSU) and supplement user subgroups (SU+CLO, SU-CLO) in EPIC-Norfolk. 
Health condition 
Answer 
category 
N % 
NSU 
N 
% 
SU+CLO 
N 
% 
SU-
CLO 
N 
% 
SU+CLO vs NSU 
OR a 
95% C.I. 
SU-CLO vs. NSU 
OR a 
95% C.I. 
MEN  10,247  6994 68.3 2215 21.6 1038 10.1     
Mean age (SD)    58.9 9.3 61.8 8.6 59.4 9.3 1.19 1.16–1.22 1.03 0.99–1.07 
Benign growth Yes 993 9.7 634 9.1 234 10.6 125 12.1 1.12 0.96–1.32 1.36 1.11–1.67 
 No 9235 90.3 6348 90.9 1975 89.4 912 87.9 Ref  Ref  
Cancer Yes 405 4.0 259 3.7 94 4.3 52 5.0 0.98 0.76–1.24 1.33 0.98–1.89 
 No 9830 96.0 6727 96.3 2117 95.7 986 95.0 Ref  Ref  
Heart attack Yes 560 5.5 409 5.9 94 4.3 57 5.5 0.58 0.46–0.74 0.90 0.68–1.20 
 No 9668 94.5 6573 94.1 2116 95.7 979 94.5 Ref  Ref  
Stroke Yes 189 1.8 139 2.0 36 1.6 14 1.4 0.65 0.45–0.94 0.64 0.37–1.12 
 No 10,041 98.2 6846 98.0 2173 98.4 1022 98.6 Ref  Ref  
High blood pressure Yes 1469 14.4 979 14.0 328 14.9 162 15.6 0.92 0.80–1.05 1.11 0.92–1.33 
 No 8753 85.6 5999 86.0 1879 85.1 875 84.4 Ref  Ref  
Diabetes Yes 333 3.3 236 3.4 69 3.1 28 2.7 0.78 0.59–1.03 0.77 0.52–1.14 
 No 9898 96.7 6747 96.6 2141 96.9 1010 97.3 Ref  Ref  
Arthritis Yes 1932 18.9 1137 16.3 604 27.4 191 18.5 1.72 1.53–1.93 1.14 0.96–1.35 
 No 8282 81.1 5837 83.7 1602 72.6 843 81.5 Ref  Ref  
Osteoporosis Yes 60 0.6 42 0.6 12 0.5 6 0.6 0.75 0.39–1.43 0.93 0.39–2.19 
 No 10,166 99.4 6940 99.4 2194 99.5 1032 99.4 Ref  Ref  
              
WOMEN  12792  7056 55.2 3389 26.5 18.3 2347     
Mean age (SD)    58.6 9.4 60.0 8.8 56.9 9.2 1.09 1.07–1.12 0.91 0.88–0.93 
Benign growth Yes 2448 19.2 1227 17.4 703 20.8 518 22.1 1.25 1.12–1.38 1.35 1.21–1.52 
 No 10,304 80.8 5812 82.6 2671 79.2 1821 77.9 Ref  Ref  
Cancer Yes 883 6.9 468 6.6 258 7.6 157 6.7 1.11 0.94–1.30 1.07 0.89–1.30 
 No 11,898 93.1 6582 93.4 3127 92.4 2189 93.3 Ref  Ref  
Heart attack Yes 168 1.3 105 1.5 39 1.2 24 1.0 0.66 0.46–0.96 0.82 0.52–1.28 
 No 12,608 98.7 6941 98.5 3345 98.8 2322 99.0 Ref  Ref  
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Table 4. Cont. 
Health condition 
Answer 
category 
N % 
NSU 
N 
% 
SU+CLO 
N 
% 
SU-
CLO 
N 
% 
SU+CLO vs NSU 
OR a 
95% C.I. 
SU-CLO vs. NSU 
OR a 
95% C.I. 
Stroke Yes 127 1.0 86 1.2 26 0.8 15 0.6 0.55 0.35–0.86 0.61 0.35–1.06 
 No 12,651 99.0 6962 98.8 3358 99.2 2331 99.4 Ref  Ref  
High blood pressure Yes 1840 14.4 1067 15.1 483 14.3 290 12.4 0.84 0.74–0.94 0.89 0.77–1.03 
 No 10,926 85.6 5977 84.9 2899 85.7 2050 87.6 Ref  Ref  
Diabetes Yes 205 1.6 139 2.0 37 1.1 29 1.2 0.50 0.35–0.73 0.69 0.46–1.03 
 No 12,571 98.4 6908 98.0 3347 98.9 2316 98.8 Ref  Ref  
Arthritis Yes 3495 27.4 1717 24.4 1195 35.4 583 25.0 1.60 1.46–1.76 1.15 1.03–1.28 
 No 9247 72.6 5316 75.6 2180 65.6 1751 75.0 Ref  Ref  
Osteoporosis Yes 340 2.7 164 2.3 100 3.0 76 3.2 1.17 0.91–1.51 1.58 1.20–2.09 
 No 12,418 97.3 6877 97.7 3276 97.0 2265 96.8 Ref  Ref  
NSU, Non-supplement User; SU, Supplement User; CLO, cod liver oil; OR, odds ratio, CI, confidence interval. a Age-adjusted OR (per 5 year) using multinomial logistic regression. Boldly printed OR were 
statistically significant findings. 
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4. Discussion 
Supplement use in EPIC-Norfolk is more prevalent among women and is associated with not 
smoking, a higher social class, higher physical activity levels and more favourable eating habits. These 
SU characteristics were found to be stronger for subgroups of SU, than for SU in general. Moreover, a 
participant’s self-report of medical conditions at baseline was associated with subgroups of supplements, 
with CLO supplements being strongly positively associated with arthritis and negatively associated with 
cardiovascular conditions. 
The associations found between supplement use in general and socio-demographic variables are in 
line with previous findings from a UK survey and cohort studies [4,5,21]. Our finding of more and 
stronger associations in women compared to men, has also been observed in the MRC National Survey 
of Health and Development [4]. However, important socio-demographic differences exist within SU. 
For example, in our study social class appeared to be mainly associated with SU-CLO use in men and 
women’s education was only associated with SU-CLO use and not SU+CLO use. Also, while most 
“unhealthy behaviours” were less prevalent among SU, exceptions were smoking and alcohol 
consumption among women in the SU-CLO group. The Norwegian Women and Cancer (NoWAC) study 
grouped participants into categories by frequency of consumption of CLO use [33]. Their average age 
of 45 years was 15 years lower than in EPIC-Norfolk; even so, participants’ age was positively associated 
with daily CLO consumption, as well as being an ex-smoker and being more physically active. Again, 
this stresses the different possible confounders within subgroups of SU. 
In EPIC-Norfolk, SU, particularly the SU+CLO group, were found to have a higher consumption of 
fruit, vegetables and fatty fish and especially the SU-CLO group had a lower consumption of red and 
processed meat compared to NSU. These associations are comparable with other studies [4,5,21,33] and 
are indicative that SU are a group of people who are least likely to need supplements. Although SU have 
in general been characterised as “healthy eating” consumers, this might not necessarily be  
so [15,34]. A longitudinal study in Switzerland found that 21% of daily/weekly vitamin and mineral SU 
were clustered around a “healthy” food pattern (16% among NSU); whereas 31% of daily/weekly 
vitamin and mineral SU consumed an “unhealthy” food pattern (compared to 39% in NSU); the SU were 
also found to have the most positive attitude towards fortification and could have used supplements as a 
means of compensation. In the current analysis, only a limited set of foods were compared between NSU 
and SU in order to avoid multiple testing, but future analyses could compare clusters of a greater variety 
of foods. 
In this cross-sectional analysis, participants who reported having had benign growths were more 
likely to report non-CLO supplement use. Cancer was not associated with supplement use in the  
EPIC-Norfolk study, contrary to what has been found in the UK Women’s Cohort Study [35]. Also the 
VITAL cohort [18] reports significant associations between high dose vitamin E and cancer in women 
as well as a study among cancer survivors [36], where only vitamin use, but not mineral, herbal or other 
types of supplement use, was associated with cancer. In the VITAL cohort, the number of supplements 
consumed among women with a medical condition was higher than in men; however, the associations 
between supplement use and medical conditions were stronger in men [18]. It was suggested that women 
might use supplements to prevent illness, whereas men might start to take supplements after diagnosis. 
In EPIC-Norfolk, the associations between supplement use and medical conditions were of similar 
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strength for men and women, but data collected at later health examinations will be able to answer 
important questions related to the onset of illness and the starting or stopping of supplement use. 
Although the time between diagnosis and the start of the use of dietary supplements is also of importance 
since participants might make a change in their habits shortly after diagnosis, but return to their former 
habits after some time has passed [36], the surveys in EPIC-Norfolk might not be frequent enough to 
capture these changes. 
A limitation of our analysis is the stratification of results into SU+CLO and SU-CLO groups, since 
this is likely to have underestimated the heterogeneity among the SU-CLO subgroup. A recent analysis 
of the Hertfordshire Cohort Study (HCS) used cluster analysis to describe five groups of SU; however, 
plant and fish oils were grouped together [15]. The aim of our analysis was to study possible confounding 
variables of participants consuming fish and CLO supplements. SU+CLO reported more illnesses such 
as arthritis and less (symptoms of) cardiovascular disease and stroke, contrary to what is reported in the 
HCS [15]. A UK survey [5] and a survey among 65-98 year old Australians [24,25] however found 
similar associations to EPIC-Norfolk. The data collected at later health examinations, will have to be 
taken into account before causal inferences between CLO and cardiovascular diseases can be made, 
especially since meta-analyses have not shown benefits [11,12]. The fact that CLO is positively 
associated with age, and that it is more likely to be taken on a daily basis, makes the SU+CLO subgroup 
of particular interest to investigate further since exposure to CLO is likely to have been for an extended 
period of time and follow-up time in this prospective cohort is by now two decades, contrary to trials. 
The nutrients of these supplements are quantified in the ViMiS database where missing values for 
omega-3 fatty acids were completed, and units of measure were made compatible for food and 
supplement sources enabling the calculation of a “total nutrient exposure” in a detailed way [8,37]. The 
wide range of endpoints collected will enable us to look at potential positive as well as harmful effects 
of CLO. 
5. Conclusions 
Significant socio-demographic associations were found in this study with weaker and fewer 
associations in SU+CLO than in SU-CLO group, especially among men. Associations between 
supplement use and age, smoking, social class and education were strong, but not uniform across all SU 
or between sexes. Participants, who had prevalent heart attack or stroke, were less likely to report CLO 
supplements; however, self-reported arthritis was associated with increased CLO use. The differences 
we found between subgroups of SU provide important information that will be necessary for later 
endpoint analysis of this and other studies, since confounding by indication as well as lifestyle 
confounders will need to be taken into account depending on the type of supplement consumed. 
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